木犀草素通过靶向Akt信号通路诱导骨髓增生异常综合征细胞线粒体依赖性凋亡与衰老OA
Luteolin induces mitochondria-dependent apoptosis and senescence in myelodysplastic syndrome cells by targeting the Akt signaling pathway
目的 骨髓增生异常综合征(myelodysplastic syndromes,MDS)患者具有较高的白血病转化风险,亟须探索新型治疗药物.基于网络药理学预测及分子对接验证,提出木犀草素(luteolin,LUT)可能通过靶向Akt信号通路诱导MDS细胞衰老与凋亡,并通过实验验证其作用靶点及分子机制.方法 通过整合PharmMapper、GeneCards等数据库,筛选出LUT与MDS的共同靶点.运用STRING数据库和 Cytoscape软件构建蛋白互作(protein-protein interaction,PPI)网络图,确定关键靶点.利用DAVID数据库对共同靶点进行GO功能分类和KEGG通路富集分析.采用AutoDock软件对LUT与关键靶点进行分子对接,并通过结合能分析对接效果.随后用Gromacs进行分子动力学模拟,观察配体与受体的相互作用和构象变化.采用MUTZ-1和MOLM-13细胞作为研究模型,不同浓度LUT处理细胞24 h后,CCK-8检测细胞活力,EdU检测细胞DNA合成能力,软琼脂实验检测细胞克隆形成,透射电镜观察细胞形态变化,流式细胞术检测细胞内活性氧(reactive oxygen species,ROS)、线粒体ROS、线粒体膜电位和细胞凋亡水平,β-半乳糖苷酶(senescence-associated β-galactosidase,SA-β-Gal)染色检测细胞衰 老 情 况,RT-qPCR 检测衰老相关分泌表型因子(senescence-associated secretory phenotype factors,SASP)mRNA表达水平,Western blotting检测相关蛋白的表达水平.结果 共筛选出LUT靶点568个,MDS相关靶点2 348个,两者交集靶点228个.将交集靶点导入DAVID数据库,GO功能富集显示,生物过程富集于氧化应激响应、细胞衰老等;细胞组分富集于蛋白激酶复合物、分泌颗粒腔等;分子功能富集于蛋白激酶活性、细胞因子受体结合等.KEGG通路富集分析显示,主要富集于Akt 信号通路、细胞衰老和凋亡等.经STRING数据库和Cytoscape软件构建PPI网络图筛选出排名前十的关键靶点,分别是IL6、NFKB1、STAT3、TNF、JUN、BCL2、ALB、CASP3、Akt1和IL1B.分子对接结果显示,LUT与Akt1的结合能为-6.25 kcal/mol,具有较强的相互作用.分子动力学模拟结果显示,LUT与靶点Akt1结合稳定.体外实验结果显示,LUT能抑制MUTZ-1和MOLM-13细胞增殖,且呈剂量依赖性.LUT作用于MUTZ-1细胞24 h后的半数抑制浓度(half-maximal inhibitory concentration,IC50)为29.960 μmol/L,作用于MOLM-13细胞24 h后IC50为8.654 μmol/L.使用不同浓度LUT(MUTZ-1:0、15、30、60 μmol/L,MOLM-13:0、4、8、16 μmol/L)处理MUTZ-1和MOLM-13细胞24 h后,可明显抑制细胞DNA合成和克隆形成(P<0.01),细胞内ROS和线粒体ROS水平增加呈剂量依赖性(P<0.05),且细胞内线粒体膜电位下降呈剂量依赖性(P<0.05).透射电镜结果显示,LUT作用24 h后MUTZ-1和MOLM-13细胞中出现明显的细胞凋亡形态.不同浓度LUT作用24 h后细胞凋亡率增加,且呈现剂量依赖性(P<0.05),Cleaved PARP和Cleaved caspase-3蛋白表达显著上调,抗凋亡蛋白BCL-2表达显著下调,促凋亡蛋白BAX表达显著上调.SA-β-Gal染色显示,LUT作用24 h后MUTZ-1和MOLM-13细胞衰老比例明显增加,相关SASP表达显著升高(P<0.001),衰老相关蛋白p53、p21、p16表达显著上调,细胞p-Akt(Ser473)蛋白表达显著下调(P<0.05),总Akt蛋白无明显变化,p-MDM2(Ser166)蛋白水平显著下调(P<0.001).结论 LUT可能通过靶向Akt信号通路诱导MDS细胞发生线粒体依赖性凋亡与衰老,从而抑制MDS细胞增殖.
Objective Myelodysplastic syndromes(MDS)are associated with a high risk of progression to leukemia,highlighting the critical need to explore novel therapeutic agents.Based on network pharmacology prediction and molecular docking,we hypothesized that luteolin(LUT)might induce cellular senescence and apoptosis in MDS cells by targeting the Akt signaling pathway.This study aims to verify its targets and molecular mechanisms through experimental studies.Methods By integrating multiple databases,such as PharmMapper and GeneCards,common targets of LUT and MDS were screened.A protein-protein interaction(PPI)network was constructed using the STRING database and visualized with Cytoscape software to identify key targets.The DAVID database was employed for the functional enrichment analysis of Gene Ontology(GO)and the pathway enrichment analysis of Kyoto Encyclopedia of Genes and Genomes(KEGG)for the common targets.Molecular docking between LUT and the key targets was performed using AutoDock software,and the docking efficacy was evaluated by analyzing the binding energy.Subsequently,molecular dynamics simulations were carried out using Gromacs to observe the ligand-receptor interactions and conformational changes.MUTZ-1 and MOLM-13 cells were used as experimental models.After treating the cells with different concentrations of LUT for 24 h(MUTZ-1:0、15、30、60 μmol/L,MOLM-13:0、4、8、16 μmol/L),cell viability was measured by CCK-8 assay,DNA synthesis capacity was assessed by EdU assay,colony formation was examined by soft agar assay,morphological changes were observed by transmission electron microscopy(TEM),intracellular reactive oxygen species(ROS),mitochondrial ROS,mitochondrial membrane potential,and apoptosis rates were detected by flow cytometry,senescence was assessed by senescence-associated β-galactosidase(SA-β-Gal)staining,mRNA expression levels of senescence-associated secretory phenotype(SASP)factors were determined by RT-qPCR,and protein expression levels were examined by Western blotting.Results A total of 568 LUT targets and 2 348 MDS-related targets were screened,yielding 228 intersecting targets.The intersecting targets were imported into the DAVID database.GO functional enrichment analysis demonstrated that biological processes were enriched in the responses to oxidative stress and cellular senescence;cellular components were enriched in protein kinase complex and secretory granule lumen;and molecular functions were enriched in protein kinase activity and cytokine receptor binding.KEGG pathway enrichment analysis revealed predominant enrichment in key pathways including the Akt signaling pathway,cellular senescence,and apoptosis.The PPI network constructed using the STRING database and Cytoscape software identified the top 10 key targets,as IL6,NFKB1,STAT3,TNF,JUN,BCL2,ALB,CASP3,Akt1 and IL1B.Molecular docking results indicated that the binding energy between LUT and Akt1 was-6.25 kcal/mol,suggesting a strong interaction.The molecular dynamics simulation results demonstrated stable binding between LUT and the Akt1 target.In vitro experimental results showed that LUT inhibited the proliferation of both MUTZ-1 and MOLM-13 cells in a dose-dependent manner.The half-maximal inhibitory concentration(IC ₅ ₀)of LUT acting on MUTZ-1 cells for 24 h was 29.960 μmol/L,and that on MOLM-13 cells for 24 h was 8.654 μmol/L.Treatment of MUTZ-1 and MOLM-13 cells with various concentrations of LUT for 24 h significantly inhibited DNA synthesis and colony formation(P<0.01).The treatment of LUT at different concentrations for 24 h resulted in significant increases in intracellular ROS and mitochondrial ROS levels in a dose-dependent manner(P<0.05),decrease in mitochondrial membrane potential in a dose-dependent manner(P<0.05),and elevation of apoptosis rates in a dose-dependent manner(P<0.05).TEM revealed obvious apoptotic morphological features in MUTZ-1 and MOLM-13 cells after 24 h of LUT treatment.The protein levels of Cleaved PARP and Cleaved caspase-3,and the pro-apoptotic protein BAX were significantly upregulated,and that of the anti-apoptotic protein BCL-2 was significantly downregulated.SA-β-Gal staining showed that the proportion of senescent cells was significantly increased in MUTZ-1 and MOLM-13 cells after LUT treatment for 24 h,along with enhanced expression of related SASP factors(P<0.001),and significant upregulation of senescence-associated proteins p53,p21 and p16.After LUT treatment for 24 h,the protein expression of p-Akt(Ser473)and p-MDM2(Ser166)was significantly downregulated,while the total Akt protein expression showed no significant change.Conclusion LUT may induce mitochondria-dependent apoptosis and senescence in MDS cells by targeting the Akt signaling pathway,thereby inhibiting the proliferation of MDS cells.
李佳润;杨学清;杨官翠;田小龙;刘金宜;张曦
陆军军医大学(第三军医大学)第二附属医院血液病医学中心,创伤与化学中毒国家重点实验室,血液病与微环境重庆市重点实验室,重庆陆军军医大学(第三军医大学)第二附属医院血液病医学中心,创伤与化学中毒国家重点实验室,血液病与微环境重庆市重点实验室,重庆陆军军医大学(第三军医大学)第二附属医院血液病医学中心,创伤与化学中毒国家重点实验室,血液病与微环境重庆市重点实验室,重庆陆军军医大学(第三军医大学)第二附属医院血液病医学中心,创伤与化学中毒国家重点实验室,血液病与微环境重庆市重点实验室,重庆陆军军医大学(第三军医大学)第二附属医院血液病医学中心,创伤与化学中毒国家重点实验室,血液病与微环境重庆市重点实验室,重庆陆军军医大学(第三军医大学)第二附属医院血液病医学中心,创伤与化学中毒国家重点实验室,血液病与微环境重庆市重点实验室,重庆
医药卫生
骨髓增生异常综合征木犀草素凋亡衰老
myelodysplastic syndromesluteolinapoptosissenescence
《陆军军医大学学报》 2026 (8)
1067-1081,15
国家自然科学基金青年项目(82300196)重庆市自然科学基金面上项目(CSTB2023NSCQ-MSX0262)重庆市医学青年拔尖人才项目(YXQN2025024) Supported by the National Natural Science Foundation for Young Scholars of China(82300196),the General Project of Nature Science Foundation of Chongqing(CSTB2023NSCQ-MSX0262),and the Young Top-Notch Medical Talent Program of Chongqing(YXQN2025024).
评论